时空步行变量和学龄前儿童的逐步变量 非常早产的儿童有发展协调障碍的风险:一项队列研究
Reem A Albesher1, Jennifer L McGinley2, Fiona L Dobson2
1Department of Rehabilitation Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Children (Basel, Switzerland)
|September 27, 2025
概括
患有发育协调障碍 (DCD) 风险非常早产的儿童表现出较差的步行表现,特别是在双重任务行走时. 对于干预来说,早期识别这些步伐赤字至关重要.
科学领域:
- 发育儿科 发育儿科
- 神经学 神经学
- 步态分析 步态分析
背景情况:
- 与满期同龄人相比,非常早产的孩子往往表现出走路障碍.
- 识别患有发育协调障碍 (DCD) 风险的非常早产儿对于早期干预至关重要.
- 非常早产儿的步行缺陷在双重任务行走时更加明显.
研究的目的:
- 为了比较 DCD 风险很高的学龄前儿童和没有风险的学龄前儿童之间的时空步行变量.
- 确定特定的步态参数,以区分具有或没有DDC风险的非常早产儿.
- 在各种条件下调查步行表现,包括首选的速度,认知双重任务,运动双重任务和双重行走.
主要方法:
- 参与者包括出生在<30周妊娠期的学龄前儿童.
- 用儿童运动评估电池第二版 (≤16百分位数),韦克斯勒学前和小学智力尺度第四版 (≥80) 和缺乏脑来定义DCD的风险.
- 使用GAITRite®在首选速度,双任务和并列条件下评估了时空步态变量.
主要成果:
- 在群体之间偏好的步行速度期间,大多数步行变量没有显著差异.
- 患有DCD风险的儿童在运动双重任务期间表现出更广泛的支持基础 (BOS) 和更短的单次支持时间.
- 在伴奏行走期间,在患有DCD风险的儿童中,观察到更广泛的BOS和更高的节奏.
结论:
- 非常早产并面临DDC风险的学龄前儿童表现出较差的行走表现,特别是在双重任务的情况下.
- 复杂的步态评估可以帮助临床医生检测风险儿童的微妙步态障碍.
- 需要进一步的研究,以探索步态变化的影响,日常功能和体育参与在这个人群.
更多相关视频
相关概念视频
01:10Nature and Nurture
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
02:20Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...